About Jeju National University Hospital
제주대학교병원은 제주특별자치도 제주시 아란13길 15 에 위치한 종합병원이다.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Jeju National University Hospital
During the past decade, Jeju National University Hospital conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 8 clinical trials were completed, i.e. on
average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 7 clinical trials were completed. i.e. 116.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Jeju National University Hospital" #1 sponsor was "Chong Kun Dang Pharmaceutical" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials
sponsored, "Jeju National University School of Medicine" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored and "Boryung Pharmaceutical Co., Ltd"
with 3 trials sponsored. Other sponsors include 19 different institutions and
companies that sponsored additional 26 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Jeju National University Hospital"
#1 collaborator was "Jeju National University Hospital" with 3 trials as a collaborator, "OCT Clinical Trials" with 3 trials as a collaborator, "Hanyang University" with 2 trials as a collaborator, "Inha University Hospital" with 2 trials as a collaborator and "Konyang University Hospital" with 2 trials as a collaborator. Other collaborators include 42 different institutions and companies that were
collaborators in the rest 48 trials.
Clinical Trials Conditions at Jeju National University Hospital
According to Clinical.Site data, the most researched conditions in "Jeju National University Hospital" are
"Rheumatoid Arthritis" (4 trials), "Coronary Artery Disease" (3 trials), "Alzheimer's Disease" (2 trials), "Atrial Fibrillation" (2 trials) and "Hepatitis B, Chronic" (2 trials). Many other conditions were trialed in "Jeju National University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Jeju National University Hospital
Most popular intervention types in "Jeju National University Hospital" are "Drug" (27 trials), "Device" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "5-year Follow-up" (1 trials), "Abilify maintena" (1 trials), "Adalimumab 40mg q2w" (1 trials) and "Anagre Cap." (1 trials). Other intervention names were less common.
Clinical Trials Genders at Jeju National University Hospital
The vast majority of trials in "Jeju National University Hospital" are
38 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Jeju National University Hospital
Currently, there are NaN active trials in "Jeju National University Hospital".
undefined are not yet recruiting,
4 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 24 completed trials in Jeju National University Hospital,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Jeju National University Hospital, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 9 trials, and there were
also 7 trials that are defined as “Not Applicable".